Dermavant Sciences Appoints Executive Chairman

Dermavant Sciences announced the appointment of Dr. Jacqualyn "Jackie" Fouse as Executive Chairman.

"I am honored to lead Dermavant and look forward to building the world's leading innovative medical dermatology company," said Fouse. "For the past decade there has been an 'innovation gap' in medical dermatology, with surprisingly few novel therapies despite a greater understanding of the pathophysiology of many dermatologic conditions. Physicians and patients are eager for better options."

Fouse previously served as President and Chief Operating Officer of Celgene Corporation until April 2017, and as a member of Celgene's Board of Directors through June 2017. She joined Celgene in 2010 as Chief Financial Officer and was named president of the company's global Hematology & Oncology franchise in 2014. Her experience at Celgene included working closely with the business unit that launched OTEZLA for the treatment of moderate-to-severe plaque psoriasis and active psoriatic arthritis.

"We are delighted to welcome Jackie to the helm of Dermavant," said Vivek Ramaswamy, Founder and Chief Executive Officer of Roivant Sciences. "She is an exceptional leader and one of the most admired executives in the biopharmaceutical industry. Jackie is emblematic of the caliber of leadership that we seek to attract to the Roivant family of companies."

Before joining Celgene, Dr. Fouse served as Chief Financial Officer of Bunge Limited, a leading global agribusiness and food company. Prior to Bunge, she served as Senior Vice President, Chief Financial Officer, and Head of Corporate Strategy at Alcon Laboratories. Prior to her tenure with Alcon, she held a variety of senior leadership roles with international companies, spending almost a decade of her career in Switzerland. Dr. Fouse earned her B.A. and M.A. in Economics and a Ph.D. in Finance from the University of Texas at Arlington.